SARBECOVIRUS

Clinical trials for SARBECOVIRUS explained in plain language.

Never miss a new study

Get alerted when new SARBECOVIRUS trials appear

Sign up with your email to follow new studies for SARBECOVIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New vaccine aims to shield against multiple coronavirus types

⭐️ VACCINE ⭐️ Recruiting now

This study tests a new vaccine called GBP511, designed to protect against several sarbecoviruses (a group that includes SARS-CoV-2). About 368 healthy adults will receive one or two doses at different strengths, with or without an adjuvant to boost immune response. The goal is to…

Matched conditions: SARBECOVIRUS

Phase: PHASE1, PHASE2 • Sponsor: SK Bioscience Co., Ltd. • Aim: ⭐️ VACCINE ⭐️

Last updated Jun 27, 2026 12:33 UTC

SARBECOVIRUS

Get alerted when new SARBECOVIRUS trials appear

New vaccine aims to shield against multiple coronavirus types